Notable FDA

FDA Seeks Input on Safe Administration Training for Future Psychedelic Therapies

HHS requests stakeholder feedback on training and care delivery models for potential FDA-approved psychedelic drugs in ambulatory settings to support safe administration. On April 18, 2026, President Trump issued Executive Order 14401, "Accelerating Medical Treatments for Serious Mental Illness,"...

The deep analysis — cross-item commentary and how this topic has evolved — is part of SignalHealth Pro.

Start a 14-day Pro trial — $9/month

Sources — verify every claim

Health and Human Services Department · Request for Information, Training and Care Delivery Models for Safe Administration of Potential FDA-Approved Psychedelic Therapies in Ambulatory Clinical Settings · Jul 14

Trust record

Verified · July 30, 2026